Protective Effect of Irbesartan by Inhibiting ANGPTL2 Expression in Diabetic Kidney Disease.
Curr Med Sci
; 40(6): 1114-1120, 2020 Dec.
Article
in En
| MEDLINE
| ID: mdl-33263178
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Diabetic Nephropathies
/
Podocytes
/
Angiopoietin-like Proteins
/
Irbesartan
/
Glucose
Type of study:
Prognostic_studies
Limits:
Animals
Language:
En
Journal:
Curr Med Sci
Year:
2020
Document type:
Article
Affiliation country:
Country of publication: